Werner syndrome cells are sensitive to DNA cross‐linking drugs
Open Access
- 5 March 2001
- journal article
- fj express-summary
- Published by Wiley in The FASEB Journal
- Vol. 15 (7) , 1224-1226
- https://doi.org/10.1096/fj.00-0611fje
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (PO1 CA77852)
This publication has 36 references indexed in Scilit:
- Functional Interaction between Ku and the Werner Syndrome Protein in DNA End ProcessingJournal of Biological Chemistry, 2000
- Werner Syndrome ProteinJournal of Biological Chemistry, 1998
- Expression cloning of a cDNA for the major Fanconi anaemia gene, FAANature Genetics, 1996
- Cell Cycle Defect in Connection with Oxygen and Iron Sensitivity in Fanconi Anemia Lymphoblastoid CellsExperimental Cell Research, 1996
- Correction: Cloning of cDNAs for Fanconi's anaemia by functional complementationNature, 1992
- The minor-groove binding DNA-ligands netropsin, distamycin A and berenil cause polyploidisation via impairment of the G2 phase of the cell cycle.Cell Structure and Function, 1990
- Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-l-sarcolysin and peptichemioEuropean Journal of Cancer and Clinical Oncology, 1987
- Prolongation of S phase and whole cell cycle in Werner's syndrome fibroblastsExperimental Gerontology, 1982
- Variegated translocation mosaicism in human skin fibroblast culturesCytogenetic and Genome Research, 1975
- A Review of its Symptomatology, Natural History, Pathologic Features, Genetics And Relationship to the Natural Aging ProcessMedicine, 1966